Factor H Antibodies

Santa Cruz Biotechnology offers a broad range of Factor H monoclonal antibodies for investigating the complement system and its regulatory mechanisms. Factor H monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Factor H is a key regulator of the complement pathway, playing a crucial role in protecting host cells from complement-mediated damage. By binding to C3b, Factor H prevents the formation of the C3 convertase, thereby inhibiting the complement cascade and maintaining immune homeostasis. Research has shown Factor H's significance in various diseases, including age-related macular degeneration and atypical hemolytic uremic syndrome, where complement system dysregulation can lead to significant pathology. Understanding Factor H's molecular mechanisms and interactions provides valuable insights into potential therapeutic strategies for complement-related disorders. Investigating Factor H's role in complement regulation can reveal new pathways for treating inflammatory conditions. Factor H monoclonal antibodies enable precise detection and analysis of complement system components in various experimental settings. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of complement system biology and developing new therapeutic approaches.